Predictors of cardiovascular events in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention for Endpoint reduction in hypertension study

Field Value
Model ID09-047-04
Model NameLosartan Intervention For Endpoint (LIFE) Risk Score - MI
Pubmed ID20001655
First AuthorKjeldsen
JournalBlood Pressure
Year2009
TitlePredictors of cardiovascular events in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention for Endpoint reduction in hypertension study
Primary Index ConditionPopulation Sample
Secondary Index ConditionHypertension
OutcomeMyocardial Infarction (MI)
Model Sample Size8624
Cohort Sample Size8624
Number of Events331
Follow-Up DurationLong (>6 months)
AUROC0.677
Calibration Reported1
CovariatesMale sex; Total cholesterol (per mmol/l); Log urinary albumin:creatinine ratio (per 10-fold); History of angina; History of diabetes; Pulse pressure (per 10 mmHg)
Mesh TermsTo be updated
Number of Validations0

External Validations